Search
We take real-world data, clean it and use it to discover new predictive biomarkers to guide cancer management (often with AI), and then implement these findings in clinical practice.
Physician-scientist Rachel Niec studies how cells and tissues communicate to promote health or drive inflammation and cancer.
The Ricardo Otazo lab develops novel magnetic resonance imaging (MRI) techniques for cancer applications including fast imaging, motion tolerant imaging, quantitative imaging of physical tissue parameters, and real-time MRI-guided radiotherapy using advances in MRI acquisition and computational models.
The goal of my research is to understand the mechanisms and structures of enzymes that perform and regulate essential nucleic acid transactions.
Lydia Finley studies the mechanisms that link metabolic pathways to cell fate decisions.
Biostatistician Colin Begg has research interests spanning cancer epidemiology and statistical methods that are applicable to clinical research more broadly.
The Sfeir Lab investigates pathways that ensure genome fidelity and plasticity.
The Aviram Lab investigates the molecular mechanisms that protect microorganisms from their own pathogenic invaders.
Molecular and cell biologist Christine Mayr studies how 3′UTRs regulate protein functions and how mRNAs contribute to cytoplasmic organization.